Hessam Kakavand

Statistics

Publications

Citations

776

H-Index

Active since

2021

Affiliations

Tehran University of Medical Sciences(Current)

Virginia Commonwealth University

NewYork–Presbyterian Hospital

Harvard University

University of Liverpool

Hessam Kakavand is an author at Tehran University of Medical Sciences specializing in antithrombotic therapy, pharmacotherapy, and thromboprophylaxis in critical illness.

ORCID

Publications per year

2021–2022

Publications

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

Saeideh Mazloomzadeh, Shiva Khaleghparast, Behshid Ghadrdoost et al. · JAMA · 2021 · 653 citations · Full text

Pharmacy, Pharmacotherapy, Critical Care Pharmacology +16

Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial

Behnood Bikdeli, Azita H. Talasaz, Farid Rashidi et al. · Thrombosis and Haemostasis · 2021 · 79 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Preprocedural Colchicine in Patients With Acute ST-elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention: A Randomized Controlled Trial (PodCAST-PCI)

Seyed Hossein Hosseini, Azita H. Talasaz, Mohammad Alidoosti et al. · Journal of Cardiovascular Pharmacology · 2022 · 34 citations

Medicine, Cardiology, Pharmacotherapy +15

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials

Azita H. Talasaz, Parham Sadeghipour, Hessam Kakavand et al. · medRxiv · 2021 · 10 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–4 of 4